Oxford and Cambridge, UK, July 7, 2010 - InhibOx Ltd (Oxford, UK) and the Cambridge Crystallographic Data Centre (Cambridge, UK) announce that they have joined forces to create a uniquely powerful drug discovery service offering. Users of the new service will benefit from the shared depth of expertise that includes extensive commercial drug discovery experience and from the leading proprietary technologies developed by the Oxford and Cambridge bodies.
